Search results
20 maj 2022 · The results of this study suggest that MC treatment is generally safe for oncology patients and can potentially reduce the burden of associated symptoms with no serious MC-related adverse effects. Keywords: medical use, cannabis, phytocannabinoids, oncology, cancer, prospective.
13 mar 2024 · PDF. In 2024, ASCO published a guideline on the use of cannabis and cannabinoids by adults with cancer. 1 The guideline provides strategies for open, nonjudgmental communication and also discusses evidence regarding cannabis and cannabinoids as cancer-directed therapy and for managing cancer symptoms and treatment side effects.
Cannabis and/or cannabinoid access and use by adults with cancer has outpaced the science supporting their clinical use. This guideline provides strategies for open, nonjudgmental communication between clinicians and adults with cancer about the use of cannabis and/or cannabinoids.
24 cze 2022 · PDF. Abstract. Cannabis use and interest continues to increase among patients with cancer and caregivers. High-quality research remains scant in many areas, causing hesitancy or discomfort among most clinical providers.
We performed a systematic review of randomized cannabis cancer trials to establish a guideline for its use in pain and to summarize the risk of harm and adverse events when used for any indication in cancer patients.
The purpose of this guideline is to guide clinicians, adults with cancer, caregivers, researchers, and oncology institutions on the medical use of cannabinoids, including synthetic cannabinoids and herbal cannabis derivatives; single, purified cannabinoids, combinations of cannabis ingredients, and full-spectrum cannabis.
22 lut 2022 · To assess the efficacy, tolerability and safety of cannabis‐based medicines, including medical cannabis, for treating pain and other symptoms in adults with cancer.
